Hesai's technological advancements and low pricing have positioned it as a dominant player in the LiDAR market, particularly ...

Shares of vTv Therapeutics rose after the Food and Drug Administration lifted a clinical hold on its diabetes treatment program. The stock gained 40% to $20.78 Monday morning. Shares have climbed ...

2-Year U.S. Treasury Note Continuous Contract $103.406-0.012-0.01% 5-Year U.S. Treasury Note Continuous Contract $107.719 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $110.734 0.094 ...

This was the stock's second consecutive day of gains.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

The fund seeks to track 3x the daily performance of the Nasdaq-100 Index, by using full replication technique. ProShares Trust - ProShares UltraPro QQQ was formed on February 9, 2010 and is domiciled ...